Back
Motley Fool Capital Efficiency 100 Index ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
65
TMFE
Motley Fool Capital Efficiency 100 Index ETF
Last Price:
$29.11
Seasonality Move:
12.72%
Sell
36
MNPR
Monopar Therapeutics, Inc.
Last Price:
$73.35
Seasonality Move:
36.18%
Buy
65
Motley Fool Capital Efficiency 100 Index ETF (TMFE)
is a Buy
Is Motley Fool Capital Efficiency 100 Index ETF a Buy, Sell or Hold?
-
The current Motley Fool Capital Efficiency 100 Index ETF [TMFE] share price is $29.12. The Score for TMFE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
TMFE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $71.47. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TMFE Stock Price Chart
What is Motley Fool Capital Efficiency 100 Index ETF's stock price today?
-
The Motley Fool Capital Efficiency 100 Index ETF share price today is $29.12The current trend is relatively stagnant and TMFE is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $71.47Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
TMFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 48.71 | Sell |
| Chaikin Money Flow: | 3256 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.68 - 29.46) | Buy |
| Bollinger Bands (100): | (28.39 - 29.43) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.27 | Sell |
| Relative Strength Index (14 RSI): | 37.77 | Sell |
| Chaikin Money Flow: | -61015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (75.54 - 86.44) | Sell |
| Bollinger Bands (100): | (44.45 - 88.87) | Buy |
TMFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.27 | Sell |
| 20-day SMA: | 29.06 | Buy |
| 50-day SMA: | 29.18 | Sell |
| 200-day SMA: | 27.79 | Buy |
| 8-day EMA: | 29.23 | Sell |
| 20-day EMA: | 29.19 | Sell |
| 50-day EMA: | 29.11 | Buy |
| 200-day EMA: | 28.09 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 76.09 | Sell |
| 20-day SMA: | 80.86 | Sell |
| 50-day SMA: | 83.38 | Sell |
| 200-day SMA: | 51.78 | Buy |
| 8-day EMA: | 75.84 | Sell |
| 20-day EMA: | 78.85 | Sell |
| 50-day EMA: | 77.98 | Sell |
| 200-day EMA: | 56.35 | Buy |
Motley Fool Capital Efficiency 100 Index ETF Earnings Growth & TMFE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Motley Fool Capital Efficiency 100 Index ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||